Lesson plan

NephroCheck

NephroCheck is a test that tries to determine the risk of some who is seriously sick developing acute kidney injury. Whether or not the test improves outcomes, however, is unclear as of 2016. NephroCheck tests for the presence of insulin-like growth-factor binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases (TIMP-2) in the urine, which are associated with acute kidney injury. The laboratory test was developed by Astute Medical, in San Diego, California.

Back to article

Article summary

NephroCheck is a test that tries to determine the risk of some who is seriously sick developing acute kidney injury. Whether or not the test improves outcomes, however, is unclear as of 2016. NephroCheck tests for the presence of insulin-like growth-factor binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases (TIMP-2) in the urine, which are associated with acute kidney injury. The laboratory test was developed by Astute Medical, in San Diego, California.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.